Fentanyl - Products, Markets, Strategies and Opportunities

Greystone Associates, November 2011

Fentanyl: Products, Markets, Strategies and Opportunities is a comprehensive evaluation and analysis of the products, demand factors and participants providing the driving force behind this evolving segment of the pain management sector.

Evolution in Pain Management Guidelines and Treatment:

As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain is increasing and placing a higher level of emphasis on pain management as a quality-of-life issue for patients and their families.

To address this trend clinicians are increasingly turning to fentanyl, a narcotic analgesic significantly more powerful than morphine that is available in sustained release dosage forms from a number of drug suppliers. Fentanyl has demonstrated effectiveness against breakthrough pain and has become a commonly prescribed pain medication for most forms of cancer. Controlled release formulations that include transdermal patches and transmucosal tablets and lozenges help address the issues of patient safety and prescription narcotic drug abuse. Pipeline products include oral inhaler and next-generation spray devices. Annual growth through 2015 will exceed ten percent on a prescription basis, but will be lower on a revenue basis due to the impact of generics.

Highlights:

- Analyzes and evaluates fentanyl products and development-stage candidates and assesses risks and market potential
- Provides assessments of pain management markets for fentanyl and examines key market and commercialization factors
- Evaluates the impact of economic, technology, and regulatory factors on opioid pain management markets
- Provides market data and forecasts to 2015
- Profiles market sector participants, their product development activities and business strategies

Who and Why Should Buy This Report:

The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, treatment segments, and commercial opportunities for this fast-growing narcotic pain medication.

Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Executive Summary

The Current Pain Management Picture
Unmet Needs in Pain Management
The Opportunity for Fentanyl

The Pain Management Market Opportunity

Evolution in Pain Management Guidelines
Regional Factors in Pain Management Practice
Pain Management Demand Drivers
Competitive Landscape
Factors Limiting Growth

Fentanyl Product Formulation and Device Strategies
Nasal Sprays
Oral Inhalers
Sublingual/Buccal
Tablets/Lozenges
Sprays
Films
Transdermal Patches

The Commercial Fentanyl Product Marketspace
FDA-Approved Fentanyl Products
Injectable/Intravenous Fentanyl
Intranasal Fentanyl
Transdermal Fentanyl
Transmucosal Fentanyl
Commercial Non-FDA Approved (Non-U.S.) Fentanyl Products
Intranasal Fentanyl
Transdermal Fentanyl
Transmucosal Fentanyl

The Fentanyl Development Pipeline
Inhaled Fentanyl Product Candidates
Iontophoretic Fentanyl Candidates
Transdermal Fentanyl Candidates
Transmucosal Fentanyl Candidates

Market and Commercialization Factors
Regional Regulations
Clinical Trials
Quality and Reliability
Indications Prescribing Guidelines and Off-Label Prescribing

Demand Picture
Critical Care Hospitals
Clinics and Ambulatory Care Facilities
Long-term Care Facilities
Hospice/End-of-Life
Home Care/Self-Administration

Market Data and Forecasts
North America
Europe
Other Geographies

Sector Participant Company Profiles

Product Samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

• Pain Therapeutics - Drugs, Markets and Companies
• Transdermal Drug Delivery - Technologies, Markets, and Companies
• Product Profiles: Moderate-To-Severe Acute Pain - Intensifying competition in breakthrough cancer pain market
• The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights
• Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta
• Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management
• Pipeline Insight: Moderate-to-Severe Acute Pain - Positive outlook for opioid-sparing analgesics
• Pain Management - Global Business Strategic Report
• The Top 50 Developers Of Pain Management Pharmaceuticals Worldwide
• The Top 30 Transmucosal Drug Delivery Technology Companies Worldwide